Home > Advisory: Prescription stimulant misuse among youth and young adults.

Substance Abuse and Mental Health Services Administration. (2021) Advisory: Prescription stimulant misuse among youth and young adults. Rockville, MD: National Mental Health and Substance Use Policy Laboratory. Substance Abuse and Mental Health Services Administration. PEP21-06-01-003.

[img]
Preview
PDF (Prescription stimulant misuse among youth and young adults)
3MB

This Advisory reviews the evidence on prescription stimulant misuse among youth and young adults. It establishes prescription stimulant misuse as a public health problem, identifies associated risk and protective factors, and provides programs and action steps for stakeholders to prevent misuse.

Item Type
Report
Publication Type
International, Report
Drug Type
CNS stimulants, Prescription/Over the counter
Intervention Type
Harm reduction
Date
November 2021
Identification #
PEP21-06-01-003
Pages
23 P.
Publisher
National Mental Health and Substance Use Policy Laboratory. Substance Abuse and Mental Health Services Administration
Corporate Creators
Substance Abuse and Mental Health Services Administration
Place of Publication
Rockville, MD
EndNote
Related (external) link

Repository Staff Only: item control page